BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9370395)

  • 1. Tumor angiogenesis and biologic markers in resected stage I NSCLC.
    Lucchi M; Fontanini G; Mussi A; Vignati S; Ribechini A; Menconi GF; Bevilacqua G; Angeletti CA
    Eur J Cardiothorac Surg; 1997 Oct; 12(4):535-41. PubMed ID: 9370395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
    Angeletti CA; Lucchi M; Fontanini G; Mussi A; Chella A; Ribechini A; Vignati S; Bevilacqua G
    Cancer; 1996 Aug; 78(3):409-15. PubMed ID: 8697384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
    Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti CA; Bevilacqua G
    J Natl Cancer Inst; 1997 Jun; 89(12):881-6. PubMed ID: 9196255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
    Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
    Fontanini G; Bigini D; Vignati S; Basolo F; Mussi A; Lucchi M; Chine S; Angeletti CA; Harris AL; Bevilacqua G
    J Pathol; 1995 Sep; 177(1):57-63. PubMed ID: 7472781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
    Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
    J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell lung carcinoma (SCLC): the angiogenic phenomenon.
    Lucchi M; Mussi A; Fontanini G; Faviana P; Ribechini A; Angeletti CA
    Eur J Cardiothorac Surg; 2002 Jun; 21(6):1105-10. PubMed ID: 12048093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer.
    Kim HS; Youm HR; Lee JS; Min KW; Chung JH; Park CS
    Lung Cancer; 2003 Nov; 42(2):163-70. PubMed ID: 14568683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma.
    Chiba Y; Taniguchi T; Matsuyama K; Sasaki M; Kato Y; Tanaka H; Muraoka R; Tanigawa N
    Surg Today; 1999; 29(11):1148-53. PubMed ID: 10552332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological prognostic factors for early stage completely resected non-small cell lung cancer.
    Cagini L; Monacelli M; Giustozzi G; Moggi L; Bellezza G; Sidoni A; Bucciarelli E; Darwish S; Ludovini V; Pistola L; Gregorc V; Tonato M
    J Surg Oncol; 2000 May; 74(1):53-60. PubMed ID: 10861611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
    Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
    Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
    Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
    Kang YH; Kim KS; Yu YK; Lim SC; Kim YC; Park KO
    J Korean Med Sci; 2001 Aug; 16(4):417-23. PubMed ID: 11511786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.
    Macchiarini P; Fontanini G; Hardin JM; Pingitore R; Angeletti CA
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):892-9. PubMed ID: 1328770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer.
    Duarte IG; Bufkin BL; Pennington MF; Gal AA; Cohen C; Kosinski AS; Mansour KA; Miller JI
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):652-8; discussion 658-9. PubMed ID: 9535454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients.
    Anagnostou VK; Tiniakos DG; Fotinou M; Achimastos A; Syrigos KN
    Virchows Arch; 2011 Mar; 458(3):331-40. PubMed ID: 21161269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.